glp 1 drugs and depression An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive mental health disorders TheCut just released an article

Although coenzyme Q 10 is generally well tolerated, there is no evidence that supplementation can improve functional and cognitive symptoms in Huntington's disease patients

They also make your body more resistant to insulin and can increase inflammation, both of which get in the way of how well GLP-1 works

Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: evidence from the LEADER trial

Detailed Mechanism of Action BPC-157's broad healing effects appear to stem from its ability to modulate multiple interconnected biological pathways simultaneously

doi: 10.1186/s12889-023-16793-3

In diabetes-related gastrointestinal complications Its metabolic regulatory properties could assist in improving abnormal gastrointestinal motility and dyspepsia, reducing symptoms such as nausea, vomiting, and constipation